🏛️ Verified NIH Record • Updated 2025-05-02
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research (NCT06222164)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Invivoscribe, Inc.
🩺 Plain-English Summary (8th-Grade Level)
Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research
Who can join: Review the eligibility criteria below.
Location: LabPMM — San Diego, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- LabPMM — San Diego, California
📞 Contact the Study Coordinator
Phone: (858) 224-6600
Email: aschut@invivoscribe.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hematologic Diseases
- Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation — Aurora, Colorado
- Bispecific CD19/CD20-Targeted Chimeric Antigen Receptor (CAR) Modified T Cells With 4-1BB and Mutated CD28 Costimulatory Domains in Patients With Relapsed or Refractory CD19+ Hematologic Malignancies — Buffalo, New York
- Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback — Palo Alto, California
- The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases — Montreal, Canada
- Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults — Palo Alto, California
Explore by condition: All Hematologic Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.